Blogs

Life-saving pharmaceutical products must reach patients in a condition that supports safety, stability, and performance. Packaging serves as the primary barrier against contamination, moisture, and gas ingress throughout distribution and storage. Container Closure Integrity (CCI) testing allows manufacturers to evaluate whether this barrier remains intact over time. As drug formulations become more complex and packaging formats continue to evolve, testing approaches have also progressed. Non-destructive CCI testing methods are increasingly used because they examine package integrity without damaging the container. These methods provide reliable insight during development, validation, and routine manufacturing while preserving valuable samples.

Limitations of Destructive Testing

Destructive CCI testing methods typically involve dye ingress, microbial challenge, or physical manipulation that permanently damages the test sample. Once tested, the package cannot be returned to the supply chain. This limits sample sizes and reduces confidence when evaluating high-value or limited-availability products such as biologics and injectable drugs.

Another drawback is variability. Many destructive techniques rely on visual interpretation, which can differ between operators. Sensitivity may also be limited, making it difficult to detect very small leak paths that still allow contamination over time. These methods are often unsuitable for in-line or high-frequency testing, creating gaps in quality monitoring. As product complexity increases, these constraints make destructive testing less practical for modern pharmaceutical operations.

What are Non-Destructive Testing Methods?

Non-destructive methods are testing techniques used to evaluate a product or package without causing damage or altering its structure, function, or usability. In pharmaceutical packaging, non-destructive methods assess container closure integrity by detecting leaks or defects while keeping the container fully intact. These techniques rely on measurable physical signals—such as pressure changes or electrical conductivity—rather than visual inspection. As a result, tested samples can be reused for further evaluation, stability studies, or release activities while still providing reliable, repeatable information about package performance.

Common non-destructive methods used in pharmaceutical CCIT include:

Vacuum decay leak testing is widely used for both rigid and flexible packaging. In this method, the package is placed inside a test chamber where a vacuum is applied. Any leak allows air to escape from the package, creating a measurable change in pressure. This approach is highly sensitive and works well for vials, blister packs, pouches, and combination products.

High Voltage Leak Detection (HVLD) is another non-destructive method used primarily for liquid-filled parenteral products. It applies a high-voltage signal across the container. When a defect is present, changes in electrical conductivity indicate the location of a leak. HVLD is suitable for prefilled syringes, ampoules, and vials containing conductive liquids.

Both methods support deterministic testing by delivering measurable data and clear pass/fail outcomes. Their adaptability across packaging formats makes them suitable for various stages of pharmaceutical manufacturing.

Benefits of Non-Destructive Testing

• Identifies very small leak paths that may not be detected by visual or destructive methods
• Preserves package integrity, allowing samples to remain usable after testing
• Supports repeat testing of the same units during stability and lifecycle studies
• Delivers objective, quantitative results with clear acceptance criteria
• Reduces product waste and material loss, especially for high-value products
• Integrates well with automated and high-throughput manufacturing environments
• Improves consistency and repeatability across testing programs
• Applies to a wide range of pharmaceutical packaging formats
• Strengthens confidence in package performance throughout storage and distribution

Non-destructive CCI testing has become a widely adopted approach for evaluating packaging used for life-saving pharmaceutical products. By overcoming the challenges associated with destructive techniques, methods such as vacuum decay and high voltage leak detection offer accurate, repeatable insight into container integrity. These technologies allow manufacturers to examine packaging performance across development and production while preserving valuable samples. Through routine application, non-destructive CCI testing supports consistent package quality, reduced material waste, and reliable protection for products intended to support patient health.